Schlagwort: Cancer
It’s time to focus on cardiovascular diseases!
To no one’s surprise, the oncology sector dominates the top deals in biopharma year by year. The industry simply ‘knows’ how to develop novel...
Can biopharma’s drug-focused R&D strategy remain profitable?
Since the 1990s, there has been a shift in focus within pharmaceutical R&D. It resulted in placing greater emphasis on areas such as cancer,...
A trimmed biotech basket
Following a strong performance in the summer period, shares of German biotech companies were affected by another global downward trend. We have adjusted the...
Advanced Therapies: Personalisierte medizinische Behandlung
Neuartige Therapien, sogenannte Advanced Therapies, stellen einen hochmodernen Bereich in der Medizin dar und bieten das Potenzial für innovative und transformative Lösungen bei der...
Defence Therapeutics Inc.: Will there soon be a vaccination against cancer?
Defence Therapeutics Inc. ("DTC") is a Canadian biotech company specialising in the development of vaccines and the improved transport of active substances into diseased...
Affimed präsentiert neue AFM13-Daten
Diese Nachricht basiert auf einer Pressemitteilung von Affimed N.V.
Affimed N.V. (Nasdaq: AFMD) präsentierte heute auf einem Poster, das auf der Jahrestagung der American Association...